Korro Bio (KRRO) Leases (2020 - 2025)
Korro Bio (KRRO) has disclosed Leases for 6 consecutive years, with $23.3 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Leases fell 2.86% year-over-year to $23.3 million, compared with a TTM value of $23.3 million through Sep 2025, down 2.86%, and an annual FY2024 reading of $23.8 million, down 12.21% over the prior year.
- Leases was $23.3 million for Q3 2025 at Korro Bio, down from $23.5 million in the prior quarter.
- Across five years, Leases topped out at $32.6 million in Q1 2021 and bottomed at $1.3 million in Q3 2023.
- Average Leases over 5 years is $25.0 million, with a median of $27.2 million recorded in 2023.
- The sharpest move saw Leases plummeted 95.47% in 2023, then soared 1693.73% in 2024.
- Year by year, Leases stood at $31.4 million in 2021, then plummeted by 93.54% to $2.0 million in 2022, then soared by 1241.4% to $27.2 million in 2023, then dropped by 12.21% to $23.8 million in 2024, then dropped by 2.11% to $23.3 million in 2025.
- Business Quant data shows Leases for KRRO at $23.3 million in Q3 2025, $23.5 million in Q2 2025, and $23.7 million in Q1 2025.